Reuters
Published Sep 16, 2021 10:37AM ET
Updated Sep 16, 2021 09:31PM ET
By Andrea Shalal
WASHINGTON (Reuters) -International Monetary Fund Managing Director Kristalina Georgieva and other multilateral-organization leaders on Thursday urged countries with high COVID-19 vaccination rates to boost efforts to send doses to low- and middle-income countries.
Georgieva and the heads of the World Bank Group, World Health Organization and World Trade Organization expressed concern in a joint statement that it would not be possible to vaccinate at least 40% of the population in all countries by the end of 2021 without urgent action.
Wide disparities in vaccination rates in advanced economies and developing countries will be a key issue raised during a virtual global summit that the United States is organizing on the sidelines of the U.N. General Assembly.
IMF spokesman Gerry Rice told reporters on Thursday that President Joe Biden had invited Georgieva to speak at the Sept. 22 event, which has not yet been formally announced by the White House. A White House spokesman declined to comment.
Reuters reported this week that the United States was pushing global leaders to endorse an even more ambitious vaccination target https://www.reuters.com/business/healthcare-pharmaceuticals/us-pushes-world-leaders-embrace-70-global-covid-19-vaccination-target-2021-09-14 at the summit: getting 70% of the world's population vaccinated by the time of the 2022 General Assembly.
The leaders said countries with high vaccination rates - which have collectively pre-purchased over 2 billion doses more than needed - should urgently swap their near-term delivery schedules with global distribution programs to help address gaps in low- and middle-income countries.
They urged high-income countries to fulfill their dose donation pledges and release vaccine companies from contracts so those doses can be delivered to people in need.
The group also urged vaccine manufacturers to prioritize and fulfill their contracts to COVAX and AVAT, an African distribution program, and improve transparency by sharing details on delivery schedules for all vaccine shipments.
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.